Nationwide data demonstrate oncological safety and functional recovery in prostate cancer patients, indicating its clinical usefulness.
Hinotori-assisted RARP showed acceptable safety and progressive functional recovery, with preliminary early oncological outcomes. These nationwide data support its safe implementation in routine clinical practice in Japan.
No takes yet. Share an insight, caveat, or question.
Hara et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: